您的位置：首页 > 产品中心 > 162054-19-5， SC-58125
SC-58125
产品别名
162054-19-5
SC-58125
5-(4-Fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)pyrazole
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C17H12N2SO2F4 |
| Molecular weight | 384.35 |
| MDL number | MFCD00930300 |
| PubChem Substance ID【PubChem化学物质编号】 | 329823724 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | SC-58125 is a selective cyclooxygenase 2 (COX-2) inhibitor. |
| Other Notes【其他说明】 | This compound was developed by Pfizer for Lipid Signaling research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
| Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| manufacturer/tradename | Pfizer® |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | DMSO: ≥20 mg/mL |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | CS(=O)(=O)c1ccc(cc1)-n2nc(cc2-c3ccc(F)cc3)C(F)(F)F |
| InChI | 1S/C17H12F4N2O2S/c1-26(24,25)14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3 |
| InChI key | JHBIMJKLBUMNAU-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
